Hi Liam,

Sorry, can't find your Trial. Have a read of this article on Geno 3 Rx options. It specifically mentions that non-nucleoside NS-5B inhibitors are pretty useless in Geno 3 ( and actually mentions ABT-333).

As we won't see Sovaldi, let alone the other new DAA's until 2015 at the earliest, it may be worth biting the bullet and trying 24 weeks of Peg/Riba. The SVR odds are 60-80%, which is not bad.

http://www.hepatitiscnewdrugresearch.com/hcv-genotype-3-ndash-the-new-treatment-challenge.html

Hey Liam

I have looked for that trial but can not find it, but you should check the drug name again as the 2nd generation Abbvie NS5A is called ABT-530

Abbvie typically will use three or four drugs in their therapy but some of the arms within the study may have less. It can be confusing the first time you hear the names and numbers so I would ask for some clarification on the possible arms that you could be randomized to.

matt 

Hi Liam, good to hear your news.  I haven`t found anything about this on the clinical trials website so it probably hasn`t been listed yet. Good to know that Abbvie are including genotype 3`s anyway. 

Best of luck!  And do keep us posted when you have some more information. 

Hi, went for an interview today for an Abbvie trial coming up, its called Abt 333/Abt267 2nd generation n55a inhibitor plus rbv has any one any knowledge of this treatment?

thanks